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Abstract
Objective—To (1) model growth in anxiety and depressive symptoms from late school age 
through young adulthood in individuals with autism spectrum disorder (ASD) and controls with 
developmental delay (DD); and (2) assess relationships between internalizing growth patterns, 
participant characteristics, baseline predictors, and distal outcomes.
Method—Data were collected between 6-24 years of age in 165 participants (n=109 with ASD; 
n=56 with nonspectrum DD), most of whom received diagnostic evaluations in both childhood 
and early adulthood. Questionnaires were collected approximately every 3-6 months between ages 
9-24. Parent-rated Child and Adult Behavior Checklists (CBCL; ABCL) and Developmental 
Behavior Checklist anxiety- and depression-related subscale distributions were modeled with 
mixed-effects Poisson models, covarying diagnosis, age, verbal IQ (VIQ), gender, and significant 
two- and three-way interactions.
Results—Anxiety was positively associated with VIQ, and controlling for VIQ, both anxiety and 
depressive symptoms were greater in ASD than nonspectrum participants. Female gender 
predicted greater increases over time in anxiety and depressive symptoms for both diagnostic 
groups. Lower maternal education was associated with increasing internalizing symptoms in a 
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subset of less verbal individuals with ASD. In exploratory post-hoc analyses, internalizing 
symptoms were associated with poorer emotional regulation in school age, and with lower life 
satisfaction and greater social difficulties in early adulthood.
Conclusion—Findings support previous claims that individuals with ASD are at particular risk 
for affect- and anxiety-specific problems. While symptom levels in females increase at a faster 
rate throughout adolescence, males with ASD appear to have elevated levels of depressive 
symptoms in school age that are maintained into young adulthood.
Keywords
autism spectrum disorder; depression; anxiety; growth curve; Child Behavior Checklist
Introduction
Mood and anxiety problems are common comorbidities in individuals with autism spectrum 
disorder (ASD), with data suggesting rates that exceed both the lifetime prevalence in the 
general population and the elevated levels seen in children with intellectual disability (ID) 
without autism.1–5 Subclinical symptom levels may be even more widespread and similarly 
impairing among people with ASD.6,7 The specific focus of this paper is how mood and 
anxiety symptoms develop over time in ASD and nonspectrum developmentally delayed 
(NSDD) samples comparatively.
Adolescence is an obvious time in which to focus on the course of internalizing 
problems.8-10 The prevalence of depression increases substantially during this period for 
typically developing youth,4,8 with approximately 14% meeting criteria for major depressive 
disorder at some point before age 18.9 To this point, research suggests that internalizing 
problems in ASD samples either improve or remain stable across adolescence; however, 
most studies are based on measures that lump depressive and anxiety symptoms, include 
very few items about either construct, or include items not specific to affect or anxiety that 
may be confounded with ASD symptoms (e.g., inattention, repetitive behavior, social 
withdrawal) 11–15 (see Supplement 1, available online, for a more detailed overview). In this 
study, we are interested in the developmental courses of cognitive-emotional symptoms of 
depression and anxiety distinctly. We model longitudinal change in individuals with ASD 
and NSDD controls on the specific depression and anxiety subscales of the well-validated 
parent-rated measures, the Child Behavior Checklist 6-18 (CBCL)16 and Adult Behavior 
Checklist (ABCL).17
The CBCL has been shown to be sensitive in detecting behavioral and emotional problems 
in adolescents with mild and moderate ID, which encompasses youth with IQ scores ranging 
from 35-69 18–20, c.f.21. In a sample of 8- to 20-year-olds with mild to profound ID 
(including IQ<20), one team18 observed that CBCL Internalizing factors were essentially the 
same as those derived from the instrument's norming sample.22 However, researchers18,19 
have noted that for both the Internalizing scale and its component Anxious/Depressed 
subscale, lower IQ was associated with fewer emotional health problems (see conflicting 
evidence in ASD14,15). To avoid potential measurement artifact in this population, we 
covaried verbal IQ (VIQ) when using the well-validated CBCL as an outcome measure for 
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our entire sample. Then, for those participants who had less than fluent speech (measured by 
clinician's module choice on the Autism Diagnostic Observation Schedule [ADOS]23), we 
also present trends over time in anxiety and depression subscales of the parent-rated 
Developmental Behavior Checklist (DBC)24, a measure specifically created for and 
validated in the intellectually and developmentally-delayed population.
Predictors and Outcome of Affective Distress in Populations With DD
Shattuck et al.14 and Gray et al.15 found that lower IQ was associated with greater emotional 
and behavioral problems in ASD. The impact of socioeconomic status (SES) on depression 
in ASD is unclear, with findings that lower SES predicts emotional problems at age 16,25 is 
not associated with emotional problems,15 predicts less improvement over time,11 and is 
associated with overall level of psychopathology but not with changes over time.26 Gender 
is another important covariate due to the complicated relations of higher rates of depression/
anxiety in females, higher rates of ASD in males, yet purportedly higher rates of depression/
anxiety in ASD than in typical samples. Finally, recent commentary suggests that emotion 
regulation27 and autism traits12 warrant study as potential mechanisms underlying affect and 
anxiety problems.
The current objectives were to (1) model growth in anxiety and depressive symptoms from 
late school age through young adulthood in a sample with heterogeneous developmental 
disorders; (2) evaluate differences in developmental patterns of internalizing symptoms 
based on diagnosis (ASD versus NSDD), verbal IQ, gender, and maternal education (as a 
proxy for SES); (3) assess relations between internalizing growth patterns, baseline 
covariates (e.g., the Emotional Control subscale of the Behavior Rating Inventory of 
Executive Function [BRIEF]28 and autism severity scores based on the ADOS symptom 
domains29), and distal outcomes (e.g., quality of life ratings).
Method
Participants and Procedures
Our sample included 165 participants with data collected between the ages of 6 and 24 
years. Of these, n=148 had between 2 and 7 repeat iterations of the parent-rated CBCL 
and/or ABCL (n=99 with ASD; n=49 with heterogeneous nonspectrum disorders or early 
delays). A subset of n=44 less verbal participants, all of whom had ASD and n=32 with 2-4 
iterations of repeat data, were also included in analyses of the DBC. See Table 1 for sample 
description by diagnostic cohort.
There was great variability in IQ in the overall sample, with VIQ scores of 10-20 at the low 
end to approximately 140 for each diagnostic group. The group with ASD tended to have 
lower VIQ (t[130]=3.94, p<.001) and chronological age at first data point (t[121]=4.11, p<.
001) than the group with NSDD, and was more likely to be male (χ2=13.03; p<.001). 
Groups with ASD and NSDD did not differ significantly on number of assessments, age at 
last assessment, race, or maternal education. Both ASD and NSDD participants came from 
two related recruitment cohorts: (1) participants in the Early Diagnosis of ASD (EDX) study 
(n=131) had been consecutive referrals at age 2 to autism specialty clinics. The group with 
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NSDD consisted of 22 children with developmental disability who were recruited from 
specialists who referred to the autism clinics, as well as those consecutive clinic referrals 
who did not receive an ASD diagnosis (n=18); these children presented with some degree of 
intellectual disability or language delay (91%) or issues such as severe attention-deficit/
hyperactivity disorder (ADHD). Most EDX participants received multiple diagnostic 
evaluations between ages 2-9 and 18-22 years, including the ADOS23 and Autism 
Diagnostic Interview-Revised (ADI-R)30 by research-reliable clinicians. See Lord et al.31 
and Anderson et al.13 for detailed descriptions of recruitment and diagnostic procedures in 
the EDX subsample. (2) An additional group (n=34) of “new recruit” participants with ASD 
and NSDD of similar ages were evaluated at the time the EDX participants were 
approximately 7-10 years old in order to increase the number of participants followed 
longitudinally through adolescence and beyond. These children were recruited from the 
community, had received at least one diagnostic evaluation prior to age 5, and received a 
comprehensive evaluation upon enrollment to confirm diagnosis.
Exclusion criteria for all participants included moderate to severe visual, hearing, or motor 
impairments. Families in both recruitment cohorts completed parent- and self-report 
questionnaires at regular intervals of 3–6 months between ages 9 and 24.
Measures
See Supplement 1, available online, for descriptions of diagnostic measures and assessment 
protocol, as well as measures used to define baseline and distal covariates.
Emotional Health—We used the CBCL and ABCL as primary outcome instruments 
because they have evidence of validation across samples both typical and with ASD, as well 
as the greatest consistency across the wide age period assessed here. We chose the 
“Anxiety” and depression-specific (CBCL: “Affective”; ABCL: “Depressive”) subscales as 
dependent variables given our interest in cognitive and emotional symptoms of depression 
and anxiety; by contrast, the commonly-used Internalizing scale includes symptoms of 
social interest and withdrawal that are likely confounded with ASD symptoms, as well as a 
greater number of items about somatic symptoms that are not specific to affective and 
anxiety problems.
Because the CBCL and ABCL are companion measures across age ranges within the 
Achenbach System of Empirically-Based Assessment (ASEBA),16,17 we will refer to the 
two collectively as “ASEBA” scales. These instruments generally have been found to have 
high sensitivity but low specificity for emotional health disorders in some samples with 
ASD,32,33 and, by contrast, to under-report emotional health problems in comparison to self- 
and teacher-report ASEBA versions in ASD.34 We modeled ASEBA variables for all 
participants, regardless of language level, after our preliminary findings indicated that 
neither verbal IQ nor ADOS module was related to rate of anxious/depressive symptom 
growth, our primary outcome of interest.
For participants with less than fluent speech, we also analyzed the Communication and 
Anxiety Disturbance (hereafter, DBC-Anxiety) and Depressive (DBC-Depressive) subtotals 
of the Developmental Behavior Checklist-Adult, a 107-item parent/caregiver-rated 
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questionnaire focusing on emotional and behavioral problems in adults 18 years and older 
with intellectual and/or developmental disabilities (IDD). In a study of 1,538 adults with 
IDD, both of these subscales had excellent internal consistency.35
Design and Analysis
Generalized mixed-effects models (GMM) were used to capture growth in the dependent 
variables (DVs; ASEBA Anxiety and Depressive subscales, DBC-Anxiety and -Depressive 
subscales). Because ASEBA items have a restricted response range (0 to 2) and 0 scores 
were common, distributions of the DVs were positively skewed, with the vast majority of 
participants scoring on the low end of the symptom scales. Thus, DV distributions better 
resembled count (Poisson) than Gaussian distributions, so mixed-effects Poisson models 
with a logarithmic link function were used to model growth in the outcome variables using 
the lme4 package36 in R version 3.0.1.37 Model parameters were estimated using Laplace 
approximation, with CIs calculated using basic, parametric bootstrap with 1,000 random 
draws. The Bayesian Information Criterion (BIC) and likelihood ratio tests aided 
comparison of competing model specifications. See Supplement 1, available online, for 
additional analytic details.
To account for potential discontinuity in growth (specifically, a sudden increase in symptom 
levels due to the transition from the CBCL to the ABCL at age 18), we included in all 
ASEBA analyses a dummy variable (measure) coding whether scores were based on the 
CBCL or ABCL. The effect of measure was positive and significant in all cases, indicating 
an increase in scores associated with the transition from the CBCL to ABCL. Significant 
effects of age (i.e., time) on symptom levels were thus indicative of increases in symptom 
levels over and above increases attributable to a change in instruments. Additionally, we 
compared linear growth models to piecewise growth models that allowed for a change in the 
rate of growth in the ASEBA subscales concomitant with the transition from the CBCL to 
the ABCL; linear growth models were preferable for both the Anxiety and Depression 
subscales.
To aid in interpretation, we report exponentiated estimates of model parameters. In Poisson 
models, these can be interpreted as incident rate ratios: What percentage increase or 
decrease in the rate of the outcome variable is expected for a one unit increase in the 
predictor, holding constant the effects of model covariates? Thus, an exponentiated estimate 
of γ̂ =2.00 associated with the regression of a count variable on sex (0=male, 1=female) 
means that females are expected to have double the rate of the outcome variable compared 
to males. Exponentiated values less than 1 reflect an expected decrease in rate with a one 
unit increase in the predictor variable, and values greater than 1 reflect an expected increase 
in rate.
Finally, in exploratory efforts, Pearson bivariate correlations were used to assess 
associations between predicted ASEBA anxiety and depressive levels and rates of growth 
over time with the following baseline and distal predictors (see Supplement 1, available 
online, for measure details): (1) the BRIEF-Emotional Control subscale as close to age 9 as 
it was available; (2) the ADOS Social Affect and Restricted Repetitive Behavior calibrated 
severity scores as close to age 9 as available; (3) Vineland Adaptive Behavior38 domain 
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standard scores at age 18; and (4) the last available iteration of the Quality of Life 
Questionnaire (QLQ)39 Satisfaction, Competence, Independence, and Social Belonging 
domains, the Well-Being Questionnaire Total40, and Family Environment Scale (FES)41 
Cohesion, Expressive, and Conflict domains (age was variable but most data came from age 
18 for all three questionnaires).
Results
ASEBA Anxiety Subscale
A linear growth model was preferable to a quadratic growth model in the ASEBA Anxiety 
subscale (BIClinear = 1,779.6 vs. BICquadratic = 1,812.3). We observed main effects of both 
VIQ and diagnosis: Higher VIQ was associated with higher levels of anxiety (γ̂ =1.005, 95% 
CI [1.001, 1.009]), and ASD was associated with higher levels of anxiety than NSDD (γ̂ 
=1.392, 95% CI [1.010, 1.885]). In the competition for variance, the effect of higher VIQ 
was ultimately quite small, whereas ASD predicted a 39% increased rate even after holding 
constant model covariates. There was also a significant interaction between age and gender 
(γ̂=0.898, 95% CI [0.816, 0.978]). At study outset in late school age, males had higher levels 
of anxiety than females (γ̂ =1.881, 95% CI [1.069, 3.490]), but females showed greater 
increases in symptoms over time throughout adolescence, with no significant gender 
difference at age 21 (γ̂=0.792, 95% CI [0.529, 1.187]). See Figure 1, including comparative 
data by gender from the ASEBA norming samples.
ASEBA Depressive Subscale
The ASEBA Combined Depressive subscale (again, labeled “Affective” on the CBCL and 
“Depressive” on the ABCL) was best described by a linear model: (BIClinear = 2,019.5 vs. 
BICquadratic = 2,039.3). We observed main effects of both diagnosis and age. ASD was 
associated with higher levels of depressive symptoms than NSDD (γ̂ =1.588, 95% CI [1.100, 
2.287]) (see Figure 2).
Depressive symptoms tended to increase over time in both diagnostic groups (γ̂=1.130, 95% 
CI [1.044, 1.227]) (see Figure 2); however, this must be interpreted in light of the significant 
interaction between age and gender (γ̂=0.889, 95% CI [0.820, 0.964]). As with the Anxiety 
subscale, males tended to have higher levels of depression than females at age 13 (γ̂=1.888, 
95% CI [1.089, 3.279]), and, on average for boys with ASD, more than double the norming 
sample mean for that age period and gender (see Figure 2 caption). However, females 
showed greater symptom increases throughout adolescence (an approximately 13% increase 
per year over the previous year's count), resulting in no gender differences by age 21 
(γ̂=0.736, 95% CI [0.460, 1.178]). Of note, we observed no significant effects of VIQ on 
depressive symptoms (γ̂=1.002, 95% CI [0.998, 1.006]).
Supplemental Figures S1 and S2 (available online) show observed ASEBA-Anxiety and 
ASEBA-Depression scores plotted against age and broken down by gender. General patterns 
of growth over time in the observed scores are similar to the patterns in the model predicted 
scores (i.e., Figures 1 and 2). Additionally, we included loess (locally weighted regression) 
lines to better capture the “jump” in ASEBA scores that coincides with the transition from 
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CBCL to ABCL (i.e., the transition from the white background to the gray shaded region). 
The jump appears to be more dramatic among females; however, in post-hoc analyses, the 
interaction between the dummy variable coding CBCL vs. ABCL and gender was not 
significant.
Anxiety and Depression Subscales in Less- Verbal Participants
We also modeled changes over time in the DBC Anxiety and Depression subscales for 
participants with less than fluent speech. This smaller subset of 44 participants all had ASD 
and were in or nearing young adulthood at the point at which their parents began completing 
DBCs (first iteration: M=19.5 years, SD=0.76).
On the DBC-Anxiety subscale, we observed no effects of VIQ or gender and no significant 
change over time in symptom levels. There was a significant interaction between age (time) 
and maternal education (our proxy for SES). Mothers without college degrees tended to 
report greater increases over time in anxiety symptoms in their children (γ̂=0.974, 95% CI 
[0.948, 0.999]).
On the DBC-Depression subscale, a main effect of age was noted in this ASD sample, with 
depressive symptoms apparently increasing from model onset around age 18 (γ̂=1.079, 95% 
CI [1.020, 1.141]). We also observed an interaction between age and gender, such that 
depressive symptom levels did not differ significantly across gender at the model outset, but 
increased for females over time at a greater rate (γ̂=0.950, 95% CI [0.911, 0.991]). Finally, a 
similar SES effect was noted for the Depressive subscale: Mothers without college degrees 
reported greater increases in their children's symptoms over the modeled time period 
(γ̂=0.952, 95% CI [0.921, 0.984]).
Potential predictors of anxiety/depressive symptoms
In both of the groups with ASD and NSDD, ASEBA symptom levels at model intercept 
were highly associated with the BRIEF-Emotional Control rating around age 9, such that 
higher initial depressive and anxiety symptoms were associated with more impaired 
emotional control (see Table 2). Most of the post-hoc correlations to the BRIEF were 
surprisingly robust, around the p <.01 or p <.001 level. Only those associations that met at 
least trend-level significance (p <.10) are displayed in Table 2 (full correlation matrix 
available from the authors).
Note that slopes of depression and anxiety subscales, indicating change over time, often had 
opposite associations with these correlates than did the intercepts. For example, greater 
impairment on the BRIEF-Emotional Control subscale was associated with greater anxiety 
and depression intercepts but lower slope values (i.e., slower-growing symptoms). We 
interpret this as natural regression to the mean, in which those with initially higher scores 
would be more likely to either get better over time or at least increase less rapidly due to 
ceiling effects.
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Potential outcomes influenced by anxiety/depressive symptoms
Higher baseline anxious/depressive symptom levels (model intercepts) tended to be 
associated with lower life satisfaction on the QLQ-Satisfaction completed in early 
adulthood. Several anxious/depressive variables were also associated post hoc with lower 
scores on Vineland Adaptive Behavior domains around age 18 (see Table 2).
Discussion
We modeled growth in anxiety and depressive symptoms from school age through young 
adulthood in participants with ASD and nonspectrum DD, focusing on differences in 
trajectory across diagnostic groups and by VIQ and gender. We found that VIQ was a 
positive predictor of anxiety but not depressive symptoms in the CBCL/ABCL models. Both 
anxiety and depressive symptoms tended to begin and remain higher in ASD compared to 
NSDD. For both types of symptoms in both diagnostic groups, females showed greater 
increases throughout adolescence on ASEBA anxious/depressive variables than did males, 
with no significant gender differences by young adulthood, although in the autism subgroup, 
this was based on a very small sample of 13 girls. Taken as a whole, these findings support 
previous claims that individuals with ASD are at particular risk for affect- and anxiety-
specific problems, with females following the course in the general population of increasing 
growth during adolescence, while males with ASD had elevated levels of depressive 
symptoms in school age that remained stable through young adulthood.
Another study objective was to assess relations between internalizing growth patterns and 
baseline and distal covariates. Higher anxious/depressive symptoms tended to be associated 
with poorer emotional regulation in school age, and lower life satisfaction and greater social 
difficulties in early adulthood.
Whereas many of our significant findings had small effect sizes, the main effects of 
diagnosis were clearly the most robust, with the group with ASD averaging anxiety totals 
nearly 1.4 times the NSDD average and depressive totals 1.6 times the NSDD average. It is 
also noteworthy that this was largely a community sample of consecutive referrals for ASD 
at age 2, and therefore these were not individuals presenting for ongoing clinical assessment 
or intervention, in which case we might expect to see higher rates of psychiatric 
comorbidities.
Our findings provide preliminary support for increases in anxiety and depressive symptoms 
in adolescent girls with developmental disabilities (including ASD), consistent with the 
course of both generalized anxiety and depression reported for typically developing (TD) 
adolescents.10,42 Particularly interesting, however, is how these results diverge from TD 
samples: In the general population, boys and girls exhibit approximately equivalent 
internalizing symptom levels until adolescence, at which point girls' growth outpaces boys' 
to result in higher overall levels, whereas in this ASD sample, anxious/depressive symptom 
levels in boys were higher than in girls at study outset and remained relatively stable over 
time, with faster female symptom growth in adolescence causing the sexes to converge by 
young adulthood. Of particular note, the average model-predicted depressive symptom level 
in school-age boys with ASD was more than double the TD norming sample mean (see 
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Figure 2 caption), indicating these problems should be a focus of future study in this gender-
by-age group.
While our sample may not be representative of the population with ASD as diagnosed today 
because of its relatively low mean IQ, VIQ was not significantly associated with growth or 
overall magnitude of parent-reported depressive symptoms in this study. By contrast, higher 
VIQ was related to greater anxiety symptoms on the CBCL/ABCL (though with a small 
effect size), and no growth over time in anxiety was noted in the less verbal, less cognitively 
able participants on the DBC analyses. It is unclear whether the relation between anxiety and 
higher verbal IQ represents an important aspect of the phenomenology of anxiety in ASD, or 
its relative ease of measurement in individuals with stronger verbal fluency or insight. In 
either case, it is interesting that the same did not apply to depressive symptoms in our 
sample.
Just as the role of SES is mixed in previous literature (see Introduction), so too did we 
observe an unusual effect in which lower maternal education was associated with greater 
internalizing symptom increases over time, but only for the analyses on less verbal 
individuals with ASD. Though we were not able to test mediation, if we assume that lower 
SES is associated with greater psychopathology due to stress-related mechanisms, we might 
have expected to see this effect in our sample regardless of verbal ability.
Our post-hoc analyses of baseline correlates were preliminary in the sense that the study was 
not designed prospectively with this in mind, and therefore somewhat differing ages at 
baseline and missing data prevented us from including emotional regulation and ASD 
severity variables as covariates within the longitudinal models themselves. However, 
associations were notably robust between internalizing model variables and the BRIEF-
Emotional Control subscale (via parent report around age 9). This suggests that emotional 
control and affective state around baseline measurement point were related and provides 
more evidence in favor of considering executive functioning, and specifically emotion 
regulation, as a mechanism underlying elevated rates of anxiety/depressive symptoms in 
ASD. These post-hoc correlations may be influenced by the use of a single informant (parent 
report); thus, it will be important to replicate in future studies using multiple-informant 
designs.
The relation of anxious/depressive symptom levels and growth to the QLQ-Satisfaction 
subscale in our group with ASD (above other quality of life subscales, e.g. independence 
and competence) suggests that these symptoms impact life satisfaction. Specific to our 
sample with ASD, several predicted modeling variables also were associated with Vineland 
Adaptive Behavior domain scores around age 18, particularly Social scores. This suggests 
effects of internalizing problems on social and other adaptive behavior deficits beyond those 
associated with ASD alone, which may shed light on findings of particularly high service 
need in individuals with ASD and comorbid psychiatric disorder.43 It also points to the need 
for thoughtful development of targeted treatments for internalizing problems in these 
populations.
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This comprised an analysis of longitudinal data from what was largely a community sample 
of a special population (i.e., consecutive referrals as toddlers, rather than a convenience 
sample of those presenting clinically at the ages of focus). The present sample included a 
comparison group with NSDD, and encompassed a wide IQ range in both diagnostic groups. 
The fact that approximately one-third of the group with NSDD originally had been referred 
for ASD evaluations suggests that the current findings may be a conservative comparison 
between these groups. Further, the low average mean IQ in the group with ASD reduces the 
representativeness of these data to more recently diagnosed samples with ASD. Our models 
are based on the unverifiable assumption (missing-at-random) that the probability of 
missingness was a function of the observed data alone (i.e., would not be altered by values 
of missing data). Finally, we did not include externalizing variables in these models but refer 
readers to a discussion of the same in a related sample.13
Psychiatric comorbidity has been tied to higher service and medication use and lower quality 
of life in the segment of the population with ASD.44,45 The availability of better-tailored 
services could decrease lengthier (thus more costly) service use. We need instrument 
validation for depression assessment in this population,33 and it likely will be valuable to 
widen our scope beyond categorical comorbidity to the pervasive issue of affective distress 
in ASD. We know little about internalizing phenomenology or prevalence in the early and 
late phases of development within DD populations. Finally, it will be important to explore 
the current gender findings to replicate and understand high rates of depressive symptoms 
specifically in school-age boys with ASD, and to see whether females' symptoms continue 
to increase in adulthood and eventually surpass males' as they age.
Clinical Guidance
• Health care providers should be aware of the need to screen for anxiety and 
depression in children and adolescents with autism spectrum disorder, particularly 
in those who exhibit emotion regulation difficulties.
• As noted in the general population, girls with ASD may have greater increases in 
anxious/depressive symptoms across adolescence than boys.
• Unlike the general population, school-age boys with ASD may present with higher 
levels of anxious/depressive symptoms than girls with ASD or same-age peers of 
either sex.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Anxiety subscale predicted scores by diagnosis and gender; by comparison, Achenbach 
System of Empirically-Based Assessment (ASEBA) norming sample16,17 raw score 
averages on the Anxiety subscale are as follows: Child Behavior Checklist (CBCL) ages 
6-11: 1.4 (boys, green square), 1.7 (girls, green circle); ages 12-18: 1.2 (boys), 1.4 (girls); 
Adult Behavior Checklist (ABCL) ages 18-35: 3.8 (men), 4.3 (women). Note: The gray 
shaded area reflects ages associated with the ABCL as opposed to the CBCL. ASD = autism 
spectrum disorder; DD = developmental delay.
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Depressive subscale predicted scores by diagnosis and gender; by comparison, Achenbach 
System of Empirically-Based Assessment (ASEBA) norming sample16,17 raw score 
averages on the Affective or Depressive subscales are as follows: Child Behavior Checklist 
(CBCL) ages 6-11: 1.4 (boys), 1.4 (girls); ages 12-18: 1.6 (boys), 1.9 (girls); Adult Behavior 
Checklist (ABCL) ages 18-35: 3.5 (men), 3.9 (women). Note: The gray shaded area reflects 
ages associated with the ABCL as opposed to the CBCL. ASD = autism spectrum disorder; 
DD = developmental delay.
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Table 1
Sample Demographics by Diagnostic Group
ASD Nonspectrum DD
N 109 56
Number assessments 1 – 7 1 – 7
3.5 (1.32) 3.4(1.37)
Verbal IQ 10 – 141 14 – 139
56.3(40.1) 79.6(33.5)
Age at First Assessment 5.9 – 19.8 7.6 – 16.7
(in years) 10.7(2.5) 12.3(2.3)
Age at Last Assessment 10.8 – 24.5 12.0 – 23.9
(in years) 19.3(3.1) 19.0(2.9)
Female 12% 39%
Non-White 20% 13%
Maternal: High School/Less 9% 23%
ADOS Social Affect 1-20 0 – 15
10.3(4.9) 3.9(3.4)
ADI-R Social 0-30 0-24
20.6(8.2) 7.6(6.4)
Note. Italicized text represents significant differences by diagnostic group at p<.05. ADI-R=Autism Diagnostic Interview-Revised; ADOS=Autism 
Diagnostic Observation Schedule; ASD = autism spectrum disorder; DD = developmental delay.
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Table 2
Significant Correlations Between Achenbach System for Empirically-Based Assessment 
measures (ASEBA) Intercepts and Slopes and Baseline and Distal Correlates
ASEBA modeled variable ASD (n=70-88) Nonspectrum DD (n=36-48)
Anxiety intercept BRIEF (r=.41, p=.001)
QLQ-Satisfaction (r=-.29, p=.01)
Vineland Social (r=-.27, p=.02)
Vineland Communication (r=-.25, p=.03)
Vineland Daily Living (r=-.31, p=.007)
BRIEF (r=.49, p=.003)
Anxiety slope BRIEF (r=-.35, p=.003)
QLQ-Satisfaction (r=-.26, p=.02)
Vineland Social (r=.29, p=.01)
Vineland Communication (r=-.27, p=.02)
Vineland Daily Living (r=.31, p=.005)
BRIEF (r=-.48, p=.003)
Depressive intercept BRIEF (r=.47, p<.001)
QLQ-Satisfaction (r=-.37, p=.001)
Vineland Social (r=-.24, p=.03)
Vineland Daily Living (r=-.21, p=.06)
Well-Being Total (r=-.22, p=.05)
FES Conflict (r=-.23, p=.06)
BRIEF (r=.56, p<.001)
QLQ-Satisfaction (r=-.45, p=.004)
Vineland Communication (r=-.31, p=.05)
Depressive slope BRIEF (r=-.37, p=.002)
QLQ-Satisfaction (r=.27, p=.02)
Vineland Social (r=.22, p=.05)
BRIEF (r=-.48, p=.003)
QLQ-Satisfaction (r=.29, p=.07)
ADOS Social Affect Severity Score (r=.29, p=.05)
Note: Italicized text represents variables approaching significance at p=0.05-0.07. ADOS = Autism Diagnostic Observation Schedule; ASD = 
autism spectrum disorder; BRIEF = Behavioral Rating Inventory for Executive Functioning-Emotional Control subscale; DD = developmental 
delay; FES = Family Environment Scale; QLQ = Quality of Life Questionnaire; Vineland = Vineland Adaptive Behavior Scales.
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